Results 251 to 260 of about 251,261 (303)

CHAtRF Modulates Cardiac Hypertrophy via SRSF5-Dependent Regulation of Psmg4 Alternative Splicing. [PDF]

open access: yesResearch (Wash D C)
Zhou LY   +12 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Hypertrophic cardiomyopathy

Lancet, The, 2013
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant, cardiovascular disorder that carries the risk of sudden cardiac death. The prevalence of HCM is 1:500 persons. The purpose of this article is to provide an overview of the pathophysiology, symptoms, complications, diagnostic testing, and treatment.
Angelos G, Rigopoulos, Hubert, Seggewiss
exaly   +11 more sources

Hypertrophic cardiomyopathy

Lancet, The, 2004
Abstract The clinical definition of hypertrophic cardiomyopathy is left ventricular hypertrophy in the absence of other causes of left ventricular hypertrophy. The size and volume of the left ventricle are usually normal or smaller. Most cases are familial disease with autosomal dominant inheritance.
Perry M Elliott
exaly   +6 more sources

Hypertrophic pachymeningitis

Child's Nervous System, 2015
Hypertrophic pachymeningitis (HP) is a rare clinical entity characterized by diffuse or localized fibrous thickening of the dura mater. It is well known but rare especially in pediatric population disease of differing origins. The primary (idiopathic) form is diagnosed after excluding other possible etiologies.
Tomasz, Dziedzic   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy